How Will Changes To Medicare Effect My Wounds?

Skin substitutes have been consistently proven to produce excellent patient outcomes, particularly in the treatment of complex and non-healing wounds, by significantly promoting faster healing and substantially reducing the risk of complications.

These advanced therapies offer a critical benefit in managing challenging wound cases that do not respond well to conventional treatments. However, Medicare is increasingly scrutinizing the use of these skin substitutes due to their perceived high costs to Medicare and growing concerns about potential overutilization.

As a result, potential changes in reimbursement policies could lead to more restrictive access to skin substitutes, thereby limiting their use in everyday clinical practice. Such limitations may ultimately impact the overall quality of patient care by reducing the availability of these effective and often essential treatment options for difficult wounds.

This situation underscores the urgent need for a balanced approach to decision-making that carefully prioritizes both cost containment and optimal patient outcomes, ensuring that patients continue to receive the best possible care without unnecessary financial barriers.

Our very own Wound Specialist, Michelle Williams, advocating for patients.